Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centruroides tecomanus Ct1a is a potent beta-mammal toxin isolated from the venom of the Mexican scorpion Centruroides tecomanus. It primarily acts as a modulator of voltage-gated sodium channels, with a high affinity for the Nav1.6 subtype. By binding to site 4 of these channels, Ct1a shifts the voltage-dependence of activation toward more negative potentials, which leads to persistent channel opening and repetitive neuronal firing. This mechanism is responsible for the severe neurotoxic symptoms observed during envenomation, including pain, paresthesia, and potentially fatal systemic effects. In therapeutic research, Ct1a is a target for the development of recombinant antivenoms and single-chain antibody fragments (scFvs) designed to neutralize its toxic effects. Additionally, it serves as a valuable pharmacological tool for studying the role of Nav1.6 channels in neuronal excitability and diseases such as Parkinson's and chronic pain.
Neutralization of the toxin's activity through high-affinity binding by single-chain variable fragments (scFvs), which prevents the toxin from interacting with site 4 of voltage-gated sodium channels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-mammal toxin Ct1a (Ct1a) (Ct1a).